EE05385B1 - LaiaspektrilisedÁ2-(asendatudÁamino)bensotiasoolsulfoonamiididÁkuiÁHIVÁproteaasiÁinhibiitorid,ÁnendeÁvalmistamismeetodÁjaÁkasutamineÁningÁfarmatseutilineÁkompositsioon - Google Patents

LaiaspektrilisedÁ2-(asendatudÁamino)bensotiasoolsulfoonamiididÁkuiÁHIVÁproteaasiÁinhibiitorid,ÁnendeÁvalmistamismeetodÁjaÁkasutamineÁningÁfarmatseutilineÁkompositsioon

Info

Publication number
EE05385B1
EE05385B1 EEP200300381A EEP200300381A EE05385B1 EE 05385 B1 EE05385 B1 EE 05385B1 EE P200300381 A EEP200300381 A EE P200300381A EE P200300381 A EEP200300381 A EE P200300381A EE 05385 B1 EE05385 B1 EE 05385B1
Authority
EE
Estonia
Prior art keywords
ákuiáhiváprotease
áamino
useunited
sulphonamides
benzothiazole
Prior art date
Application number
EEP200300381A
Other languages
English (en)
Inventor
Dominique�Louis�Nestor�Ghislain�Surleraux
Piet�Tom�Bert�Paul�Wigerinck
Daniel�Getman
Wim�Gaston�Verschueren
Sandrine�Marie�Helene�Vendeville
Marie-Pierre�T.M.M.G�De�Bethune
Jan�Octaaf�Antoon�De�Kerpel
Samuel�Leo�Christiaan�Moors
Herman�Augustinus�De�Kock
Marieke�Christiane�Johanna�Voets
Original Assignee
Tibotec�Pharmaceuticals�Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tibotec�Pharmaceuticals�Ltd. filed Critical Tibotec�Pharmaceuticals�Ltd.
Publication of EE200300381A publication Critical patent/EE200300381A/et
Publication of EE05385B1 publication Critical patent/EE05385B1/et

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D277/82—Nitrogen atoms
EEP200300381A 2001-02-14 2002-02-14 LaiaspektrilisedÁ2-(asendatudÁamino)bensotiasoolsulfoonamiididÁkuiÁHIVÁproteaasiÁinhibiitorid,ÁnendeÁvalmistamismeetodÁjaÁkasutamineÁningÁfarmatseutilineÁkompositsioon EE05385B1 (et)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP01200529 2001-02-14
US28775801P 2001-05-02 2001-05-02
PCT/EP2002/001788 WO2002083657A2 (en) 2001-02-14 2002-02-14 Broadspectrum 2-(substituted-amino)-benzothiazole sulfonamide hiv protease inhibitors

Publications (2)

Publication Number Publication Date
EE200300381A EE200300381A (et) 2003-12-15
EE05385B1 true EE05385B1 (et) 2011-02-15

Family

ID=26076833

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200300381A EE05385B1 (et) 2001-02-14 2002-02-14 LaiaspektrilisedÁ2-(asendatudÁamino)bensotiasoolsulfoonamiididÁkuiÁHIVÁproteaasiÁinhibiitorid,ÁnendeÁvalmistamismeetodÁjaÁkasutamineÁningÁfarmatseutilineÁkompositsioon

Country Status (31)

Country Link
US (1) US7659404B2 (et)
EP (1) EP1370543B1 (et)
JP (1) JP4530612B2 (et)
KR (1) KR100870184B1 (et)
CN (2) CN100369904C (et)
AP (1) AP1504A (et)
AT (1) ATE343567T1 (et)
AU (1) AU2002302363B2 (et)
BG (1) BG66301B1 (et)
BR (1) BR0207862A (et)
CA (1) CA2438304C (et)
CY (1) CY1108073T1 (et)
CZ (1) CZ304273B6 (et)
DE (1) DE60215623T2 (et)
DK (1) DK1370543T3 (et)
EA (1) EA006096B1 (et)
EE (1) EE05385B1 (et)
ES (1) ES2275866T3 (et)
HK (1) HK1061233A1 (et)
HR (1) HRP20030735B1 (et)
HU (1) HU229224B1 (et)
IL (2) IL157171A0 (et)
MX (1) MXPA03007236A (et)
NO (1) NO326174B1 (et)
NZ (1) NZ527391A (et)
PL (1) PL213327B1 (et)
PT (1) PT1370543E (et)
SI (1) SI1370543T1 (et)
SK (1) SK287582B6 (et)
WO (1) WO2002083657A2 (et)
ZA (1) ZA200306086B (et)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0011555A (pt) 1999-05-28 2002-02-26 Virco Nv Perfis mutacionais em transcriptase reversa de hiv-1 correlacionada com resistência fenotìpica à droga
CA2425807A1 (en) 2000-10-20 2002-04-25 Virco Bvba New mutational profiles in hiv-1 reverse transcriptase correlated with phenotypic drug resistance
DK1370543T3 (da) 2001-02-14 2007-02-19 Tibotec Pharm Ltd Bredspektrede 2-(substitueret amino) benzothiazol- sulfonamid-HIV-proteaseinhibitorer
WO2003057173A2 (en) 2002-01-07 2003-07-17 Sequoia Pharmaceuticals Broad spectrum inhibitors
US7157489B2 (en) 2002-03-12 2007-01-02 The Board Of Trustees Of The University Of Illinois HIV protease inhibitors
EP1522039B1 (en) 2002-07-01 2008-06-04 Tibotec Pharmaceuticals Ltd. New mutational profiles in hiv-1 reverse transcriptase correlated with phenotypic drug resistance
EP1520247B1 (en) 2002-07-01 2009-05-27 Tibotec Pharmaceuticals Ltd. Mutational profiles in hiv-1 protease correlated with phenotypic drug resistance
CN101445493A (zh) * 2002-08-02 2009-06-03 泰博特克药品有限公司 广谱2-氨基-苯并噻唑磺酰胺类hiv蛋白酶抑制剂
KR20050025647A (ko) * 2002-08-02 2005-03-14 티보텍 파마슈티칼즈 리미티드 광범위 2-아미노-벤조티아졸 설폰아미드 ｈｉｖ프로테아제 저해제
AP1985A (en) * 2003-09-30 2009-03-30 Tibotec Pharm Ltd Methods for the preparation of benzoxazole sulfonamide compounds and intermediates thereof
DE10360835A1 (de) * 2003-12-23 2005-07-21 Boehringer Ingelheim Pharma Gmbh & Co. Kg Bicyclische Imidazolverbindungen, deren Herstellung und deren Verwendung als Arzneimittel
CN1997363B (zh) * 2004-05-07 2012-03-28 塞阔伊亚药品公司 抗耐药性反转录病毒蛋白酶抑制剂
ES2331257T3 (es) 2005-02-25 2009-12-28 Tibotec Pharmaceuticals Sintesis de precursores de inhibidores de proteasas.
AR053845A1 (es) 2005-04-15 2007-05-23 Tibotec Pharm Ltd 5-tiazolilmetil[(1s,2r)-3-[[(2-amino-6-benzoxazolil)sulfonil)](2-metilpropil)amino]-2-hidroxi-1-(fenilmetil)propil]carbamato como mejorador de farmacos metabolizados por el citocromo p450
JO2841B1 (en) 2006-06-23 2014-09-15 تيبوتيك فارماسيوتيكالز ليمتد 2-(substituted-amino) -benzothiazole sulfonamide as protease inhibitors HIV (HIV)
WO2011061590A1 (en) 2009-11-17 2011-05-26 Hetero Research Foundation Novel carboxamide derivatives as hiv inhibitors
JO3090B1 (ar) * 2009-12-11 2017-03-15 Janssen Sciences Ireland Uc 5- امينو-4- هيدروكسي-بنتويل اميدات
US9024038B2 (en) 2010-12-27 2015-05-05 Purdue Research Foundation Compunds and methods for treating HIV
RU2014115227A (ru) 2012-04-20 2015-10-27 Джилид Сайэнс, Инк. Производные бензотиазол-6-ил уксусной кислоты и их примение для лечения вич-инфекции
CN104000824B (zh) * 2014-05-28 2016-07-06 中山大学 苯并五元杂环类化合物在制备抗hiv-1病毒药物中的应用
US11439608B2 (en) 2017-09-25 2022-09-13 Qun Lu Roles of modulators of intersectin-CDC42 signaling in Alzheimer's disease

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0445926B1 (en) 1990-03-09 1996-08-21 Milliken Research Corporation Organic materials having sulfonamido linked poly(oxyalkylene) moieties and their preparation
US5145684A (en) 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
DK0656887T3 (da) * 1992-08-25 1999-07-05 Searle & Co Hydroxyethylaminosulfonamider til anvendelse som inhibitorer af retrovirale proteaser
PH30929A (en) 1992-09-03 1997-12-23 Janssen Pharmaceutica Nv Beads having a core coated with an antifungal and a polymer.
IS2334B (is) 1992-09-08 2008-02-15 Vertex Pharmaceuticals Inc., (A Massachusetts Corporation) Aspartyl próteasi hemjari af nýjum flokki súlfonamíða
DE69415326T2 (de) * 1993-08-24 1999-06-02 Searle & Co Hydroxyaminosulfonamide verwendbar als inhibitoren retroviraler proteasen
EP0721331B1 (en) 1993-10-01 2001-12-05 AstraZeneca AB Process i
DE69637380T2 (de) 1995-01-20 2009-09-17 G.D. Searle Llc, Chicago Bis-sulfonamid-hydroxyethylamino-derivate als inhibitoren retroviraler proteasen
US6140505A (en) 1995-03-10 2000-10-31 G. D. Searle & Co. Synthesis of benzo fused heterocyclic sulfonyl chlorides
US5756533A (en) * 1995-03-10 1998-05-26 G.D. Searle & Co. Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
US6143788A (en) * 1995-03-10 2000-11-07 G.D. Searle & Co. Bis-amino acid hydroxyethlamino sulfonamide retroviral protease inhibitors
US5705500A (en) 1995-03-10 1998-01-06 G.D. Searle & Co. Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors
DE69625183T2 (de) * 1995-03-10 2003-10-09 Searle & Co Heterocyclocarbonyl-aminosäure-hydroxyethylamino-sulfonamid inhibitoren retroviraler proteasen
US6861539B1 (en) * 1995-03-10 2005-03-01 G. D. Searle & Co. Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
US6150556A (en) 1995-03-10 2000-11-21 G. D. Dearle & Co. Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
CA2236236A1 (en) 1995-11-15 1997-05-22 G.D. Searle & Co. Substituted sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors
DE69726729T2 (de) 1996-05-20 2004-12-02 Janssen Pharmaceutica N.V. Fungizide mittel mit verbesserter bioverfügbarkeit
HU224217B1 (hu) 1997-03-26 2005-06-28 Janssen Pharmaceutica N.V. Gombaellenes hatóanyaggal és polimerrel bevont magrészt tartalmazó pelletek
WO1999033792A2 (en) 1997-12-24 1999-07-08 Vertex Pharmaceuticals Incorporated Prodrugs os aspartyl protease inhibitors
US6436989B1 (en) 1997-12-24 2002-08-20 Vertex Pharmaceuticals, Incorporated Prodrugs of aspartyl protease inhibitors
ID25551A (id) * 1997-12-24 2000-10-12 Vertex Pharma Bahan baku obat penghambat protease aspartil
WO1999033795A1 (en) 1997-12-24 1999-07-08 Vertex Pharmaceuticals Incorporated Prodrugs of aspartyl protease inhibitors
NZ508855A (en) * 1998-06-19 2003-10-31 Vertex Pharma Sulfonamide inhibitors of HIV aspartyl protease
WO1999067254A2 (en) 1998-06-23 1999-12-29 The United States Of America Represented By The Secretary, Department Of Health And Human Services Multi-drug resistant retroviral protease inhibitors and use thereof
CA2872424C (en) * 1998-06-23 2017-03-07 The United States Of America, Represented By The Secretary, Department Of Health And Human Services Bisfuran derivatives useful in preventing the emergence of multidrug resistant hiv strains and treatment of hiv
AR031520A1 (es) 1999-06-11 2003-09-24 Vertex Pharma Un compuesto inhibidor de aspartilo proteasa, una composicion que lo comprende y un metodo para tratar un paciente con dicha composicion
DK1370543T3 (da) 2001-02-14 2007-02-19 Tibotec Pharm Ltd Bredspektrede 2-(substitueret amino) benzothiazol- sulfonamid-HIV-proteaseinhibitorer

Also Published As

Publication number Publication date
ATE343567T1 (de) 2006-11-15
AP1504A (en) 2005-12-10
PL213327B1 (pl) 2013-02-28
KR100870184B1 (ko) 2008-11-24
ES2275866T3 (es) 2007-06-16
IL157171A0 (en) 2004-02-08
BR0207862A (pt) 2004-06-22
CZ304273B6 (cs) 2014-02-12
HUP0303257A2 (hu) 2004-01-28
SI1370543T1 (sl) 2007-04-30
PL363778A1 (en) 2004-11-29
BG66301B1 (bg) 2013-03-29
SK11022003A3 (sk) 2004-07-07
CA2438304A1 (en) 2002-10-24
JP2004518767A (ja) 2004-06-24
WO2002083657A3 (en) 2003-02-13
NZ527391A (en) 2005-04-29
CZ20032415A3 (cs) 2004-04-14
WO2002083657A2 (en) 2002-10-24
EP1370543B1 (en) 2006-10-25
AP2003002856A0 (en) 2003-09-30
CN101230067A (zh) 2008-07-30
NO326174B1 (no) 2008-10-13
CY1108073T1 (el) 2014-02-12
CA2438304C (en) 2011-04-12
EP1370543A2 (en) 2003-12-17
DK1370543T3 (da) 2007-02-19
SK287582B6 (sk) 2011-03-04
IL157171A (en) 2012-10-31
JP4530612B2 (ja) 2010-08-25
NO20033584L (no) 2003-10-14
HK1061233A1 (en) 2004-09-10
HU229224B1 (en) 2013-09-30
EA200300891A1 (ru) 2004-02-26
CN1525962A (zh) 2004-09-01
DE60215623D1 (de) 2006-12-07
PT1370543E (pt) 2007-02-28
KR20030077017A (ko) 2003-09-29
EE200300381A (et) 2003-12-15
AU2002302363B2 (en) 2008-05-01
US7659404B2 (en) 2010-02-09
HRP20030735A2 (en) 2005-08-31
MXPA03007236A (es) 2003-12-04
ZA200306086B (en) 2005-01-26
CN100369904C (zh) 2008-02-20
BG108143A (en) 2004-07-30
DE60215623T2 (de) 2007-08-30
HRP20030735B1 (en) 2012-02-29
NO20033584D0 (no) 2003-08-13
US20040116485A1 (en) 2004-06-17
EA006096B1 (ru) 2005-08-25
CN101230067B (zh) 2011-06-15

Similar Documents

Publication Publication Date Title
EE05385B1 (et) LaiaspektrilisedÁ2-(asendatudÁamino)bensotiasoolsulfoonamiididÁkuiÁHIVÁproteaasiÁinhibiitorid,ÁnendeÁvalmistamismeetodÁjaÁkasutamineÁningÁfarmatseutilineÁkompositsioon
NO20033556D0 (no) Farmasöytiske preparater
DK1478339T3 (da) Farmaceutiske formuleringer af antineoplastiske midler, specielt temozolomid, fremgangsmåder til fremstilling og anvendelse heraf
IS7714A (is) Lyfjasamsetningar úr módafíníl
AU2002363236A1 (en) Compounds, pharmaceutical compositions and methods of use therefor
NO20033384L (no) Farmasoytisk formulering
NO20040356L (no) Indaneddiksyrederivater og deres andvendelse som farmasoytiske midler, intermediater og fremgangsmate for fremstilling.
NO20033785L (no) Farmasöytisk formulering
NO20044192L (no) 17alfa-alkyl-17beta-oksy-ostratriener og farmasoytiske preparater
NO20024528L (no) Proteaseinhibitor, farmasoytisk sammensetning og anvendelse av forbindelsen
NO20041272L (no) Tetracycline derivatives and methods of use thereof
NO20040268L (no) Nye 2H-pyridazin-3-derivater, farmasoytiske preparater inneholdende slike og fremgangsmate for fremstilling av den aktive ingrediensen
IS2707B (is) Nýjar lyfjasamsetningar úr módafíníli
NO20044916L (no) Preparater av sulfinylacetamid
IS7798A (is) Efnasambönd, lyfjablöndur og aðferðir
NO20035627D0 (no) Farmasöytisk formulering
NO20033854L (no) N-but-3-enyl-norbuprenorfin og fremgangsmåter for anvendelse
NO20035328D0 (no) Nye forbindelser og preparater som katepsinhibitorer
NO20033506L (no) Parasitticidale preparater og metoder for anvendelse
IS6956A (is) Sítrat salt af 5,8,14,-tríasatetrasýkló[10.3.1.02,11.04,9]-hexadeka-2(11),3,5,7,9-pentaen og lyfjafræðilegar samsetningar af því
DK1387838T3 (da) Cyanoanthranylamid-derivater og deres anvendelse som lægemidler
EE200300501A (et) Ninna manustatavad imidasotriasinooni sisaldavad kompositsioonid
EE05384B1 (et) LaiaspektrilisedÁ2-(asendatudÁamino)bensoksasoolsulfoonamiididÁkuiÁHIVÁproteaasiÁinhibiitorid,ÁnendeÁkasutamine,ÁfarmatseutilineÁkompositsioonÁjaÁmeetodÁretroviiruseÁreplikatsiooniÁinhibeerimiseks
DK1407780T3 (da) Farmaceutisk stabile hæmostatiske præparater
NO20041485L (no) Farmasoytisk formulering omfattende (R)-bicalutamid

Legal Events

Date Code Title Description
HE1A Change of address
HE1A Change of address
MM4A Lapsed by not paying the annual fees

Effective date: 20160214